Comparing DCBs in De Novo CAD: Drugs, Design Matter
At TCT 2023, two studies of sirolimus- vs paclitaxel-coated devices reached different conclusions about 6-month late lumen loss.
Source: tctmd.com
Sequent Please News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Sequent Please. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Sequent Please Today - Breaking & Trending Today
Comparing DCBs in De Novo CAD: Drugs, Design Matters
At TCT 2023, two studies of sirolimus- vs paclitaxel-coated devices reached different conclusions about 6-month late lumen loss.
Source: tctmd.com
Long-term Data Support Paclitaxel-Coated Balloons for In-Stent Restenosis
The DCB performed as well as a DES at 10 years, with similar rates of TLR despite leaving nothing behind in the artery.
Source: tctmd.com
TRANSFORM 1 Aufnahme abgeschlossen: Eine wichtige RCT, dazu bereit, den DCB-Angioplastie-Mechanismus neu zu definieren
/PRNewswire/ -- Concept Medical gibt den erfolgreichen Abschluss der TRANSFORM 1 RCT bekannt (TReAtmeNt of Small coronary vessels: Randomized controlled trial...
Source: prnewswire.com
Concept Medical Inc.: Much Awaited, Much Needed: TRANSFORM II Randomized Controlled Trial, by Fondazione RIC, gets rolling
MILANO, Italy, Jan. 28, 2022 /PRNewswire/ -- FONDAZIONE Ricerca e Innovazione Cardiovascolare, Milano, focused on cardiovascular research, reports the first patient enrolment of the TRANSFORM
Source: finanznachrichten.de